Other languages Zimmer Biomet Holdings, Inc. London S.E.

Equities

0QQD

US98956P1021

Market Closed - London S.E. Other stock markets 08:11:26 29/01/2021 pm IST			5-day change	1st Jan Change
136.1 ^CHF	+6.20%		-.--%	-.--%

02/07	Evercore ISI Adjusts Price Target on Zimmer Biomet Holdings to $115 From $130, Maintains In-Line Rating	MT
01/07	Zimmer Biomet Shares Fall Following Piper Sandler Downgrade	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zimmer Biomet Shares Fall Following Piper Sandler Downgrade	02/07
Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors	20/06
Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health	12/06
RevelAi Health and Zimmer Biomet Holdings, Inc. Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value-Based Care and Health Equity Through AI-Powered Technology	12/06
Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI Miniature Handheld Robotic System for Total Knee Arthroplasty	11/06
Zimmer Biomet Holdings Insider Sold Shares Worth $1,474,582, According to a Recent SEC Filing	05/06
Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says	01/06
EE.UU. - Valores a seguir en Wall Street (actualizado)	31/05
Zimmer Biomet Outlines Growth Strategy Through 2027; Board Approves $2 Billion Stock Buyback	30/05
Zimmer Biomet Holdings, Inc. announces an Equity Buyback for $2,000 million worth of its shares.	30/05
Zimmer Biomet Holdings, Inc. authorizes a Buyback Plan.	29/05
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024, Payable on or About July 31, 2024	13/05
Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices	02/05
Zimmer Biomet Holdings Q1 Adjusted Earnings, Net Sales Rise; 2024 Outlook Reiterated	02/05
Zimmer Biomet Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Zimmer Biomet Holdings, Inc. Reiterates Financial Guidance for Current Full-Year 2024	02/05
Medartis steigert Umsatz deutlich und schreibt wieder Gewinn	12/03
Zimmer Biomet's ROSA Shoulder Replacement Platform Receives FDA Clearance	22/02
Zimmer Biomet Holdings, Inc. Announces U.S. Food and Drug Administration 510(K) Clearance of the Rosa® Shoulder System for Robotic-Assisted Shoulder Replacement Surgery	22/02
Zimmer Biomet Holdings, Inc. Announces Quarterly Cash Dividend for the First Quarter of 2024, Payable on or About April 30, 2024	21/02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Zimmer Biomet Holdings, Inc. London S.E.

Equities

0QQD

US98956P1021

Other languages

Filters